Who owns AVEO Pharmaceuticals?

Key details on AVEO Pharmaceuticals (Ticker: AVEO)

Who owns AVEO Pharmaceuticals?

Is AVEO a good stock to own? Find out who bought AVEO Pharmaceuticals, who sold AVEO Pharmaceuticals (AVEO) stock, and who holds a large position in AVEO Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Baupost 3.83M $4.25M Sept. 30, 2014
Dr. Jeffrey R. Jay, M.D. 2.33M $4.25M June 30, 2014
Sarissa Capital Management 2.31M $4.03M June 30, 2015
BlackRock Institutional Trust Company, N.A. 2.27M $3.95M June 30, 2015
Vanguard 2.13M $3.68M June 30, 2015
ALLIANCEBERNSTEIN 2.10M $26.09M March 31, 2012
Gruss Asset Management 1.56M $2.72M June 30, 2015
BlackRock Fund Advisors 1.44M $2.14M March 31, 2014
MPM Asset Management 1.37M $2.51M Dec. 31, 2013
Renaissance Technologies 1.28M $1.85M March 31, 2015
BlackRock Advisors 1.16M $2.90M June 30, 2013
Wellington Management Company 1.03M $2.57M June 30, 2013
Deutsche Bank Aktiengesellschaft 923850 $1.90M Sept. 30, 2013
AQR Capital Management 917507 $2.29M June 30, 2013
TCW 908419 $9.46M Sept. 30, 2012
FMR 870455 $1.60M Dec. 31, 2013
D. E. Shaw & Co 845751 $710430 Dec. 31, 2014
Credit Suisse AG 841034 $2.10M June 30, 2013
Technical Financial Services 833762 $1.72M Sept. 30, 2013
STATE STREET CORPORATION 759446 $1.13M March 31, 2014
NORTHERN TRUST 716756 $1.30M Dec. 31, 2013
GRANAHAN INVESTMENT MANAGEMENT INC/MA 684651 $1.19M June 30, 2015
Deer VI & Co 675242 $1.17M June 30, 2015
Fore Research & Management 674200 $1.23M June 30, 2014
Palo Alto Investors 669449 $562337 Dec. 31, 2014

Who sold AVEO Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Sectoral Asset Management June 30, 2011 1.22M $25.23M
Alyeska Investment March 31, 2011 754447 $10.05M
OrbiMed Advisors Dec. 31, 2010 953581 $13.94M
Brookside Capital Management, LLC* Dec. 31, 2010 883958 $12.92M